← 返回前沿论文

多组学分析确定 GAA 是血管免疫母细胞性 T 细胞淋巴瘤的独立不良预后生物标志物和候选治疗靶点

英文原题:Multi-omics analysis identifies GAA as an independent poor prognostic biomarker and candidate therapeutic target in angioimmunoblastic T-cell lymphoma.

PubMed 2026/08/11(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

研究概要

我们的研究确定GAA是与AITL不良临床结局、免疫微环境特征及代谢通路改变相关的候选生物标志物,突显糖原代谢作为一个此前未被充分探索的生物学轴以及值得进一步功能研究的潜在治疗脆弱点。

研究思路结论见上方概要

血管免疫母细胞性T细胞淋巴瘤(AITL)是外周T细胞淋巴瘤的一种侵袭性亚型,临床结局差且治疗选择有限。代谢重编程和免疫微环境改变对AITL进展的贡献仍未被充分阐明。

我们对AITL样本与反应性淋巴组织增生进行了整合转录组学和蛋白质组学分析,以识别与治疗反应和预后相关的分子。进行了免疫浸润和通路富集分析,并在独立的GEO队列(GSE19069和GSE58445)中验证了发现。通过免疫组织化学和多重免疫荧光确认了关键蛋白的表达。

差异表达分析显示,溶酶体α-葡萄糖苷酶(GAA),一种参与糖原代谢的关键酶,在标准化疗失败患者的RNA和蛋白质水平上均显著上调。多因素分析显示,GAA表达升高与较差的总生存期相关。免疫组织化学染色和多重免疫荧光进一步证实了GAA在AITL组织中的空间表达模式。免疫解卷积和通路富集分析提示,GAA高表达肿瘤表现出CD8+ T细胞浸润增加,伴随T细胞耗竭的转录特征,以及以糖酵解相关特征增强和氧化磷酸化相关特征降低为特点的转录推断代谢改变。这些发现在来自GEO数据库的独立AITL队列中得到了进一步验证。

展开英文摘要原文

BACKGROUND: Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive subtype of peripheral T-cell lymphoma with poor clinical outcomes and limited therapeutic options. The contribution of metabolic reprogramming and immune microenvironmental alterations to AITL progression remains insufficiently defined. METHODS: We conducted integrative transcriptomic and proteomic analyses of AITL samples compared with reactive lymphoid hyperplasia to identify molecules associated with treatment response and prognosis. Immune infiltration and pathway enrichment analyses were performed, and findings were validated in independent GEO cohorts (GSE19069 and GSE58445). Key protein expression was confirmed by immunohistochemistry and multiplex immunofluorescence. RESULTS: Differential expression analyses revealed that lysosomal alpha-glucosidase (GAA), a key enzyme involved in glycogen metabolism, was significantly upregulated at both the RNA and protein levels in patients who failed to respond to standard chemotherapy. Elevated GAA expression was associated with inferior overall survival in multivariate analysis. Immunohistochemistry staining and multiplex immunofluorescence further confirmed the spatial expression pattern of GAA in AITL tissues. Immune deconvolution and pathway enrichment analyses suggested that GAA-high tumors exhibited increased CD8 + T-cell infiltration accompanied by transcriptional features of T-cell exhaustion, as well as transcriptionally inferred metabolic alterations characterized by enhanced glycolysis-related signatures and reduced oxidative phosphorylation-related signatures. These findings were further validated in an independent AITL cohort from the GEO database. CONCLUSIONS: Our study identifies GAA as a candidate biomarker associated with adverse clinical outcomes, immune microenvironmental features, and metabolic pathway alterations in AITL, highlighting glycogen metabolism as a previously underexplored biological axis and a potential therapeutic vulnerability warranting further functional investigation.

论文信息

作者
Liu Y、Shi Y、Zhao Y、Wang H、Mi L、Wu M、Song Y、Zhu J
单位
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.China
期刊
Frontiers in immunology2026
原文标识
PubMed 42643572 · DOI 10.3389/fimmu.2026.1862168